loader image
Wednesday, October 29, 2025
76.8 F
McAllen
- Advertisement -

Valley Baptist Neuroscience Department Participates in Groundbreaking Stroke Research

Translate to Spanish or other 102 languages!

Dr. Ameer Hassan, an investigator in the trial and head of the Neuroscience Department, Director of Endovascular Surgical Neuroradiology, and Director of Clinical Neuroscience Research at Valley Baptist Medical Center-Harlingen. Photo Mega Doctor News
Dr. Ameer Hassan, an investigator in the trial and head of the Neuroscience Department, Director of Endovascular Surgical Neuroradiology, and Director of Clinical Neuroscience Research at Valley Baptist Medical Center-Harlingen. Photo Mega Doctor News

Mega Doctor News

- Advertisement -

Harlingen/Brownsville – As it relates to ischemic stroke treatment, patients and physicians have often relied on the saying “time equals brain” – meaning that the faster a patient is able to receive medical treatment, the greater chance that they will experience a successful recovery.

Previously, that time was proven to be a six-hour window, during which physicians could utilize a combination of medication and/or endovascular treatment to treat stroke patients. But according to a recent study published in the November 2017 edition of the New England Journal of Medicine in which the Valley Baptist Medical Center-Harlingen Neuroscience Program was a participant, that treatment window can be as long as 24 hours for some patients.

“The DAWN trial looked at stroke patients from 6 to 24 hours, a group of patients that have never been looked at before and proved that actually performing mechanical thrombectomy significantly benefitted patients,” said Dr. Ameer Hassan, an investigator in the trial and head of the Neuroscience Department, Director of Endovascular Surgical Neuroradiology, and Director of Clinical Neuroscience Research at Valley Baptist Medical Center-Harlingen. “This is a big deal because we as physicians never had anything for patients outside of the six-hour window.”

- Advertisement -

Traditionally, many stroke patients seeking medical treatment within six hours are treated with a combination of IV-tPA – a medication that works to dissolve the blood clot responsible for a stroke – and mechanical thrombectomy, a procedure in which an endovascular neurologist inserts a catheter into a patient’s leg through the blood vessels to the brain to remove the clot, thereby reopening the clogged vessel and restoring blood flow to the brain.

“We’ve had IV TPA since the late 1990s, which is FDA-approved through up to three hours. Some patients can get it up to four and a half hours,” Hassan said. “Then we had endovascular treatment, which was proven in 2015 to benefit patients through up to six hours. Now we have something to show that some patients can still benefit after having a stroke up to 24 hours if they have favorable imaging.”

Hassan said that as part of the study, patients received a number of tests to determine if they were viable candidates prior to treatment. Those who showed the necessary results and went on to receive endovascular treatment often experienced significant outcomes, Hassan said. “In the study, 49 percent of patients treated had complete functional independence at 90 days,” he said.

The findings are significant because most stroke patients, including those in the Rio Grande Valley, seek medical treatment after the six-hour window. Recent studies suggest that just 5 to 13 percent of patients receive treatment within three to six hours.

- Advertisement -

“If you suffer a stroke in the Valley, most people in Cameron County know that Valley Baptist is a Comprehensive Stroke Center, but they also know that time is brain, and if a patient did not come in within six hours, there may not have been much to offer them,” Hassan said. “The majority of patients in South Texas present after six hours, hence the importance of this research for a region like ours.”

The recently-published study continues Valley Baptist-Harlingen’s participation in ground-breaking stroke research. Hassan and the Valley Baptist-Harlingen neuroscience research program also participated in the 2015 SWIFT PRIME study, which was also published by the New England Journal of Medicine and revealed that adding endovascular treatment to traditional stroke care could result in improved long-term functional outcomes for patients.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Renaissance Cancer Foundation’s 15th Anniversary Gala Event, Nov. 15th

The Renaissance Cancer Foundation, a non-profit organization with DHR Health, is excited to announce its 15th Anniversary Gala, featuring the Miami sounds of music group, The Clique. The event is set to take place on November 15, 2025 at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado in Edinburg.

University of Houston & DHR Health Multi-Million Dollar Medical Research & Education Center in the RGV

The University of Houston and DHR Health Hospital System today announced an agreement to establish The University of Houston Tilman J. Fertitta Family College of Medicine and DHR Health Medical Research and Education Center in the Rio Grande Valley.

Persistence in Adversity Foundation Launches 6th Annual Blanket Drive

Dr. Esmeralda Adame, founder of the Persistence in Adversity Foundation, is once again rallying the Rio Grande Valley community for a cause that brings both warmth and compassion. The foundation has launched its 6th Annual Blanket Drive, aiming to collect 1,000 new blankets for families, the elderly, and those in need across the region.

“I Was Diagnosed with Lung Cancer and Cured in Just 14 Days,” said Juan Camacho

In a landmark moment for healthcare in the Rio Grande Valley, DHR Health has achieved dual national recognition as both a Center of Excellence in Lung Cancer Screening and a Center of Excellence in Lung Cancer Care by GO2 for Lung Cancer, a leading organization dedicated to improving outcomes and survival rates for patients facing lung cancer.
- Advertisement -
×